Literature DB >> 18332923

Cystadenoma of the liver without mesenchymal stroma in a female following hormonal therapy for acne.

E Dixon1, F R Sutherland, K Burak, G McKinnon, G May.   

Abstract

BACKGROUND: Liver cystadenomas are relatively rare tumours that can be difficult to diagnose; treatment entails complete surgical extirpation either by either anatomical resection or enucleation. CASE OUTLINE: A 19-year-old woman presented with acute onset of abdominal pain and was found to have a multilocular giant liver cyst.The cyst was percutaneously drained; CEA and CA 19-9 tumour markers were elevated in this cyst fluid: CEA 96 microg/L, CAI9-9 37 550 kU/L. The cyst was completely enucleated and has not recurred. Pathological examination confirmed a cystadenoma without mesenchymal stroma, and tumour oestrogen and progesterone receptors were negative. DISCUSSION: This is the fourth report of a liver cystadenoma without mesenchymal stroma in a female and the first to document elevated cyst fluid tumour markers. This case also illustrates the possible relationship between hormonal therapy and tumour growth.

Entities:  

Year:  2001        PMID: 18332923      PMCID: PMC2020801          DOI: 10.1080/136518201317077224

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  18 in total

1.  CA 19-9 production by a cystadenoma with mesenchymal stroma of the common hepatic duct: a case report.

Authors:  E Caturelli; M Bisceglia; M R Villani; G de Maio; D A Siena
Journal:  Liver       Date:  1998-06

2.  Immunohistochemical demonstration of progesterone receptor in hepatobiliary cystadenoma with mesenchymal stroma.

Authors:  W Grayson; J Teare; J A Myburgh; A C Paterson
Journal:  Histopathology       Date:  1996-11       Impact factor: 5.087

3.  Serum and cystic fluid CA 19-9 determinations as a diagnostic help in liver cysts of uncertain nature.

Authors:  Y Horsmans; A Laka; J F Gigot; A P Geubel
Journal:  Liver       Date:  1996-08

Review 4.  Hepatobiliary cystadenoma with mesenchymal stroma.

Authors:  O E Akwari; A Tucker; H F Seigler; K M Itani
Journal:  Ann Surg       Date:  1990-01       Impact factor: 12.969

Review 5.  Mucinous biliary cystadenoma with mesenchymal stroma: expressions of CA 19-9 and carcinoembryonic antigen in serum and cystic fluid.

Authors:  J H Lee; D R Chen; S C Pang; Y S Lai
Journal:  J Gastroenterol       Date:  1996-10       Impact factor: 7.527

6.  Cystadenoma with mesenchymal stroma (CMS) in the liver and bile ducts. A clinicopathologic study of 17 cases, 4 with malignant change.

Authors:  D A Wheeler; H A Edmondson
Journal:  Cancer       Date:  1985-09-15       Impact factor: 6.860

7.  Elevated serum CA 19-9 levels in hepatobiliary cystadenoma with mesenchymal stroma. Two case reports with immunohistochemical confirmation.

Authors:  J A Thomas; M W Scriven; M C Puntis; B Jasani; G T Williams
Journal:  Cancer       Date:  1992-10-01       Impact factor: 6.860

Review 8.  Biliary cystadenoma of the liver.

Authors:  K Kim; J Choi; Y Park; W Lee; B Kim
Journal:  J Hepatobiliary Pancreat Surg       Date:  1998

9.  Hepatobiliary cystadenoma and cystadenocarcinoma. A light microscopic and immunohistochemical study of 70 patients.

Authors:  K Devaney; Z D Goodman; K G Ishak
Journal:  Am J Surg Pathol       Date:  1994-11       Impact factor: 6.394

10.  Fine needle aspiration of cystic liver lesions. Cytologic examination and carcinoembryonic antigen assay of cyst contents.

Authors:  M M Pinto; A D Kaye
Journal:  Acta Cytol       Date:  1989 Nov-Dec       Impact factor: 2.319

View more
  2 in total

1.  Hepatobiliary cystoadenoma: a wolf in sheep's clothing.

Authors:  Giuseppe Navarra; Domenico Rosario Iusco; Serena Bonomi; Antonio Grassi; Ismail Ismail; Susanna Vicari; Salvatore Virzì
Journal:  Updates Surg       Date:  2010-12-03

Review 2.  Cystic neoplasms of the liver: biliary cystadenoma and cystadenocarcinoma.

Authors:  Kevin C Soares; Dean J Arnaoutakis; Ihab Kamel; Robert Anders; Reid B Adams; Todd W Bauer; Timothy M Pawlik
Journal:  J Am Coll Surg       Date:  2013-09-14       Impact factor: 6.113

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.